Ignite Creation Date:
2025-12-25 @ 12:04 AM
Ignite Modification Date:
2026-01-01 @ 8:44 PM
Study NCT ID:
NCT05128058
Status:
COMPLETED
Last Update Posted:
2023-11-13
First Post:
2021-10-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Target Occupancy Study With Ritlecitinib.
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-10-22
Start Date Type:
ACTUAL
Primary Completion Date:
2022-01-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-01-14
Completion Date Type:
ACTUAL
First Submit Date:
2021-10-15
First Submit QC Date:
None
Study First Post Date:
2021-11-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-12-15
Results First Submit QC Date:
None
Results First Post Date:
2023-11-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-09
Last Update Post Date:
2023-11-13
Last Update Post Date Type:
ACTUAL